Skip to Main Content

Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria

Conditions

Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum | Diseases of the Kidney & Urinary Tract

Phase III

What is the purpose of this trial?

Brief Summary:

The purpose of this study is to determine the efficacy and safety of ALLN-177 in patients with enteric hyperoxaluria

  • Trial with
    Allena Pharmaceuticals, Inc.
  • Start Date
    06/27/2019
  • End Date
    07/30/2019
Trial Image

For more information about this study, contact:

Lauren Liberti

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    09/18/2019
  • Study HIC
    #2000024788